Clinical Trial Update: Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides [Phase 1]

View source ↗

Summary

Phase I trial of a virosome-formulated peptide vaccine for chronic hepatitis C has completed the Phase I stage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Virosome-formulated peptides vaccine (virosome-formulated peptides vaccine)

Snippet

Sponsor: Pevion Biotech Ltd | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED